JP2023543149A5 - - Google Patents

Info

Publication number
JP2023543149A5
JP2023543149A5 JP2023515678A JP2023515678A JP2023543149A5 JP 2023543149 A5 JP2023543149 A5 JP 2023543149A5 JP 2023515678 A JP2023515678 A JP 2023515678A JP 2023515678 A JP2023515678 A JP 2023515678A JP 2023543149 A5 JP2023543149 A5 JP 2023543149A5
Authority
JP
Japan
Prior art keywords
composition
composition according
urolithin
cells
nad
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023515678A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023543149A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/076654 external-priority patent/WO2022064061A1/en
Publication of JP2023543149A publication Critical patent/JP2023543149A/ja
Publication of JP2023543149A5 publication Critical patent/JP2023543149A5/ja
Priority to JP2026010816A priority Critical patent/JP2026090303A/ja
Pending legal-status Critical Current

Links

JP2023515678A 2020-09-28 2021-09-28 幹細胞機能を向上させるための組成物及び方法 Pending JP2023543149A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026010816A JP2026090303A (ja) 2020-09-28 2026-01-26 幹細胞機能を向上させるための組成物及び方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20198620.5 2020-09-28
EP20198620 2020-09-28
PCT/EP2021/076654 WO2022064061A1 (en) 2020-09-28 2021-09-28 Compositions and methods for increasing stem cell function

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026010816A Division JP2026090303A (ja) 2020-09-28 2026-01-26 幹細胞機能を向上させるための組成物及び方法

Publications (2)

Publication Number Publication Date
JP2023543149A JP2023543149A (ja) 2023-10-13
JP2023543149A5 true JP2023543149A5 (cg-RX-API-DMAC7.html) 2024-06-07

Family

ID=72665073

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023515678A Pending JP2023543149A (ja) 2020-09-28 2021-09-28 幹細胞機能を向上させるための組成物及び方法
JP2026010816A Pending JP2026090303A (ja) 2020-09-28 2026-01-26 幹細胞機能を向上させるための組成物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026010816A Pending JP2026090303A (ja) 2020-09-28 2026-01-26 幹細胞機能を向上させるための組成物及び方法

Country Status (8)

Country Link
US (1) US20240010981A1 (cg-RX-API-DMAC7.html)
EP (1) EP4217471A1 (cg-RX-API-DMAC7.html)
JP (2) JP2023543149A (cg-RX-API-DMAC7.html)
CN (1) CN116234900A (cg-RX-API-DMAC7.html)
AU (1) AU2021348257A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023005370A2 (cg-RX-API-DMAC7.html)
CA (1) CA3188629A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022064061A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2023237544A1 (en) * 2022-03-22 2024-10-31 Amazentis Sa Compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723315A (en) 1996-08-23 1998-03-03 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
CZ297278B6 (cs) 1996-08-07 2006-10-11 Darwin Discovery Limited Deriváty hydroxamové a karboxylové kyseliny a jejich pouzití
US6126939A (en) 1996-09-03 2000-10-03 Yeda Research And Development Co. Ltd. Anti-inflammatory dipeptide and pharmaceutical composition thereof
CN101172140B (zh) * 2007-09-11 2011-12-28 珍奥集团股份有限公司 促进造血干细胞增殖与血红蛋白合成的营养组合物
EP2995948A1 (en) * 2014-09-09 2016-03-16 Ecole Polytechnique Federale de Lausanne (EPFL) Methods and compounds useful in hematopoietic stem cell medicine
CN104830772A (zh) * 2015-05-28 2015-08-12 深圳富利鑫健康产业发展有限公司 一种造血干细胞培养基及其应用和干细胞培养方法
EP3393467B1 (en) * 2015-12-24 2020-07-01 Amazentis SA Compositions comprising nicotinamide riboside and a urolithin
CN105838675A (zh) * 2016-06-07 2016-08-10 广东万海细胞生物科技有限公司 一种造血干细胞无血清培养基
US20220241240A1 (en) * 2019-01-18 2022-08-04 Societe Des Produits Nestle S.A. Agents and methods for increasing stem cell function
CN113613663B (zh) * 2019-03-29 2024-09-03 雀巢产品有限公司 用于增加t细胞功能的组合物和方法

Similar Documents

Publication Publication Date Title
US20250235488A1 (en) Compositions and methods for providing hematopoietic function
Macmillan et al. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I–II clinical trial
US20190298778A1 (en) Compositions and methods for providing hematopoietic function without hla matching
CA2711549C (en) Method of producing a population of cells
JP7793284B2 (ja) 高活性nk細胞の処理方法
Lee et al. Apple ethanol extract promotes proliferation of human adult stem cells, which involves the regenerative potential of stem cells
JP2023542640A5 (cg-RX-API-DMAC7.html)
US20080075704A1 (en) Method of providing readily available cellular material derived from peripheral blood, and a composition thereof
KR20130015481A (ko) 적혈구의 인 비트로 대량 생산방법 및 이의 저장 방법
US12551523B2 (en) HIF-1 activator
JP2023543149A (ja) 幹細胞機能を向上させるための組成物及び方法
JP2023542640A (ja) 幹細胞機能を向上させるための組成物及び方法
JP2024516187A5 (cg-RX-API-DMAC7.html)
JP7497094B1 (ja) 腸内細菌叢改善のための組成物及びその応用
Soboleva Blood in a lab: using immortalized erythroid cell lines as a source for blood transfusion
JP2018050551A (ja) 造血幹細胞の分化促進剤
Cancelas On how Rac controls hematopoietic stem cell activity
Bhattacharya et al. Frontiers of cord blood science
Shin et al. Quercetin 3-O-β-(2”-galloyl)-rhamnopyranoside promotes the differentiation of hematopoietic stem cells or early progenitor cells into erythroid lineage in mice
HK40095240A (en) Compositions and methods for increasing stem cell function
HK40096626A (en) Compositions and methods for increasing stem cell function
JP6268015B2 (ja) 造血幹細胞の増殖促進剤および未分化維持剤
CHAO et al. Effects of paeoniflorin on the proliferation of bone marrow mesenchymal stem cells
CA2597963A1 (en) Method of providing readily available cellular material derived from peripheral blood and a composition thereof
Kunisawa Vitamin B9 and ATP in the control and development of intestinal inflammation